Perrigo Co PLC (PRGO)

PRGO (NYSE:Drugs) EQUITY
$155.14
pos +2.40
+1.60%
Today's Range: 152.58 - 155.29 | PRGO Avg Daily Volume: 940,200
Last Update: 02/26/15 - 3:59 PM EST
Volume: 862,489
YTD Performance: -8.63%
Open: $153.22
Previous Close: $152.73
52 Week Range: $125.37 - $172.00
Oustanding Shares: 140,794,919
Market Cap: 21,609,204,168
6-Month Chart
TheStreet Ratings Grade for PRGO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 9
Moderate Buy 2 2 2 2
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.27 1.39 1.39 1.42
Latest Dividend: 0.12
Latest Dividend Yield: 0.33%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: 56.01
Price Earnings Comparisons:
PRGO Sector Avg. S&P 500
56.01 57.10 26.88
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.39% -5.22% 58.70%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.70 0.47 0.14
Net Income -53.50 -0.40 -0.15
EPS -62.20 -0.51 -0.21
Earnings for PRGO:
EBITDA 0.98B
Revenue 4.06B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (06/15) FY (06/16)
Average Estimate $1.84 $2.28 $7.35 $8.56
Number of Analysts 9 9 11 11
High Estimate $2.00 $2.47 $7.46 $9.09
Low Estimate $1.76 $2.08 $7.25 $8.00
Prior Year $1.31 $1.74 $6.39 $7.35
Growth Rate (Year over Year) 40.20% 31.16% 15.02% 16.44%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It might be good for consumers, but not for the stock.
Throughout this historic run, four groups have consistently led the market.
Still, it's a good time to review what's happening, so we never forget.
Yep, the bets for the rest of 2014 are being placed.
A wave of M&A in the health sector makes sense.
Bearish
May 08, 2014 | 7:39 AM EDT
PRGO was downgraded from Top Pick to Outperform, RBC Capital said. $160 price target. Company lacks near-term catalysts. 
Bullish
Mar 03, 2014 | 7:55 AM EST
PRGO upped its number, UBS said. Driven by synergy from Elan deal  and JAI and D5 deals. $190 price target and Buy rating. 
What's setting the turnstiles in motion?
Bullish
Jan 07, 2014 | 8:39 AM EST
PRGO was upgraded to Buy, Bank of America/Merrill Lynch said. $171 price target. Company will likely continue to be active acquirers.

Columnist Conversations

I know right JC! It's that zombie that refuses to go away. (the company recently announced the closure of my ...
If you follow the oil markets this is a must read! http://www.platts.com/latest-news/oil/americas/hollyfrontie...
Many of the same 'talking heads' who thought rates would rise in 2014 now believe that rates will decline in 2...
I don't know, Soz, they cant kill this thing but I like your thoughts!

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.